Celebrates Second Anniversary at On the Grass
Music Festival Over 420 Holiday
PHOENIX, May 01, 2019 (GLOBE NEWSWIRE) -- Item 9
Labs Corp. (INLB) (âItem 9 Labsâ or
the âCompanyâ), a leader in comfortable cannabis health solutions
for the modern consumer, celebrated its second anniversary by
investing in community at Arizonaâs On the Grass Music Festival,
April 19th and 20th, at Fear Farm Sports
& Entertainment Complex in Phoenix.
Item 9 Labs sponsored the two-day reggae event
during the 420-holiday weekend and provided 100 exclusive gift
boxes for social and dispensary giveaways. More than 15,000 concert
goers attended to hear the bands Slightly Stoopid, Iration, Sublime
with Rome, Dirty Heads, Pepper and others.
âThe On the Grass Music Festival provided a
vibrant venue for Item 9 Labs street team to tap into the local
community and spread brand awareness,â stated CEO Sara
Item 9 Labsâ on-site activation lounge offered
concert goers a shaded area to socialize with couches and bar top
tables. Additional highlights included Kush Cash, promotional
goodies, and a photo station where attendees could pose with a
giant Item 9 Labs delta triangle.
Headquartered in southern Arizona, Item 9 Labs
has received multiple awards for its cannabis flower strains. The
Company has developed a diverse product line of proprietary THC and
CBD-derived delivery systems, including its Intra-Nasal device and
Apollo Vape Pen and Pod System.
For information visit Item9LabsCorp.com.
About Item 9 Labs Corp.:
Item 9 Labs Corp. (INLB)
creates comfortable cannabis health solutions for the modern
consumer. The Company is bringing best of industry practices to
markets from coast to coast through cultivation and production,
distinctive retail environments, licensing services, and diverse
product suites catering to different medical cannabis demographics.
Item 9 Labs Corp. is headquartered in Phoenix, Arizona, with
medical cannabis operations in multiple U.S. markets.
Item 9 Labs Corp.âs asset portfolio includes
Dispensary Permits, Dispensary Templates, and Strive Life. These
assets provide services specific to different stakeholder groups.
Dispensary Permits is the Companyâs consulting firm specializing in
strategic license application and compliance. Dispensary Templates,
a subdivision of the firm, is a technology platform with an
extensive digital library of licensing and business planning
resources. Strive Life is a turnkey dispensary model for the retail
sector, elevating the patient experience with consistent and
superior service, high-end design, and precision-tested products.
It is currently being implemented in Arizona and North Dakota.
In addition, Item 9 Labs Corp. is advancing the
industry with its dynamic product suites. The Company has created
complementary brands Item 9 Labs and Strive Wellness to channel
consumer diversity. Propriety delivery platforms include the Apollo
Vape and Pod system, as well as a pioneering intra-nasal device.
The Company has received multiple accolades for its medical-grade
flower and concentrates.
Item 9 Labs Corp. will be managing cultivation,
processing, distribution, and dispensary operations in up to ten
U.S. markets by the end of 2019. Current facilities include
distribution and processing operations Strive Wellness of Ohio and
Strive Wellness of Nevada, as well as dispensary Strive Life North
For more information, visit Item 9 Labs Corp.
Statement: This press release contains
forward-looking statements within the meaning of the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Such statements involve risks and uncertainties, including, but not
limited to, risks and effects of legal and administrative
proceedings and governmental regulation, especially in a foreign
country, future financial and operational results, competition,
general economic conditions, proposed transactions that are not
legally binding obligations of the company and the ability to
manage and continue growth. Should one or more of these risks or
uncertainties materialize, or should underlying assumptions prove
incorrect, actual outcomes may vary materially from those
indicated. Important factors that could cause actual results to
differ materially from the forward-looking statements we make in
this news release include the introduction of new technology,
market conditions and those set forth in reports or documents we
file from time to time with the SEC. We undertake no obligation to
revise or update such statements to reflect current events or
circumstances after the date hereof or to reflect the occurrence of
Item 9 Labs Corp.
Photos accompanying this announcement are